Atara Biotherapeutics (ATRA) Current Deferred Revenue (2020 - 2026)
Atara Biotherapeutics (ATRA) reported Current Deferred Revenue of $775,000 for Q2 2026, down 51.8% from $1.61 million a year earlier but up 13.3% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Atara Biotherapeutics posted Current Deferred Revenue of $716,000, down 99.2% from FY2024.
- Current Deferred Revenue has a five-year compound annual growth rate of -53.6% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $95.09 million in FY2024 (+22.2%), $77.83 million in FY2023 (+872.9%), $8 million in FY2022 (-80.4%) and $40.76 million in FY2021 (+21.8%).
- Five-year quarterly Current Deferred Revenue spans a low of $684,000 in Q1 2026 and a high of $123.15 million in Q1 2024.
- Year over year, Current Deferred Revenue has now declined in each of the last six quarters, with growth averaging 49.1% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2024 (growth of 902.0%); the low point was Q4 2025 (a decline of 99.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $684,000 (Q1 2026), $716,000 (Q4 2025) and $1.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Atara Biotherapeutics | 141.16 Mn | 131.26 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 775,000.00 |
| Mar 31, 2026 | 684,000.00 |
| Dec 31, 2025 | 716,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 15.98 Mn |
| Dec 31, 2024 | 95.09 Mn |
| Sep 30, 2024 | 116.34 Mn |
| Jun 30, 2024 | 107.58 Mn |
| Mar 31, 2024 | 123.15 Mn |
| Dec 31, 2023 | 77.83 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 11.95 Mn |
| Mar 31, 2023 | 9.92 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 50.94 Mn |
| Dec 31, 2021 | 40.76 Mn |
| Sep 30, 2021 | 31.23 Mn |
API Access
Atara Biotherapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();